Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$8.48 - $14.97 $229,417 - $404,998
27,054 New
27,054 $404,000
Q2 2021

Aug 16, 2021

SELL
$6.21 - $7.45 $205,190 - $246,162
-33,042 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$4.16 - $6.26 $52,124 - $78,437
12,530 Added 61.09%
33,042 $196,000
Q2 2020

Aug 17, 2020

BUY
$3.47 - $9.99 $71,176 - $204,914
20,512 New
20,512 $106,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About AVEO PHARMACEUTICALS, INC.


  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.